Terms: = Liver cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
47 results:
1. Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study.
Piscaglia F; Ikeda K; Cheng AL; Kudo M; Ikeda M; Breder V; Ryoo BY; Mody K; Ren M; Ramji Z; Sung MW
Cancer; 2024 Apr; 130(8):1281-1291. PubMed ID: 38261521
[TBL] [Abstract] [Full Text] [Related]
2. Primary tumor resection improves survival benefit of stage IVB cervical carcinoma: a new perspective.
He Y; Zhang Y; Hu S; Zhang B; Zhang Z; Yao Y; Wang X
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11013-11023. PubMed ID: 37335336
[TBL] [Abstract] [Full Text] [Related]
3. Organ Transplants From Deceased Donors With Primary Brain Tumors and Risk of cancer Transmission.
Greenhall GHB; Rous BA; Robb ML; Brown C; Hardman G; Hilton RM; Neuberger JM; Dark JH; Johnson RJ; Forsythe JLR; Tomlinson LA; Callaghan CJ; Watson CJE
JAMA Surg; 2023 May; 158(5):504-513. PubMed ID: 36947028
[TBL] [Abstract] [Full Text] [Related]
4. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract] [Full Text] [Related]
5. treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
Dietz MV; Ziekman MJ; van Kooten JP; Brandt-Kerkhof ARM; van Meerten E; Verhoef C; Madsen EVE
Ann Surg Oncol; 2023 Apr; 30(4):2048-2056. PubMed ID: 36566258
[TBL] [Abstract] [Full Text] [Related]
6. Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl4‑induced liver fibrosis using RNA‑sequencing.
Wang T; Zhu J; Gao L; Wei M; Zhang D; Chen L; Wu H; Ma J; Li L; Zhang N; Wang Y; Xing Q; He L; Hong F; Qin S
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 36004475
[TBL] [Abstract] [Full Text] [Related]
7. First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 Probody.
Kist de Ruijter L; Hooiveld-Noeken JS; Giesen D; Lub-de Hooge MN; Kok IC; Brouwers AH; Elias SG; Nguyen MTL; Lu H; Gietema JA; Jalving M; de Groot DJA; Vasiljeva O; de Vries EGE
Clin Cancer Res; 2021 Oct; 27(19):5325-5333. PubMed ID: 34253583
[TBL] [Abstract] [Full Text] [Related]
8. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
[TBL] [Abstract] [Full Text] [Related]
9. [Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma].
Gao X; Li Z; Shao XY; Liu XM; Liu C; Liu YP; Qu XJ; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):569-573. PubMed ID: 34034477
[No Abstract] [Full Text] [Related]
10. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
[TBL] [Abstract] [Full Text] [Related]
11. Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.
Okusaka T; Ikeda K; Kudo M; Finn R; Qin S; Han KH; Cheng AL; Piscaglia F; Kobayashi M; Sung M; Chen M; Wyrwicz L; Yoon JH; Ren Z; Mody K; Dutcus C; Tamai T; Ren M; Hayato S; Kumada H
J Gastroenterol; 2021 Jun; 56(6):570-580. PubMed ID: 33948712
[TBL] [Abstract] [Full Text] [Related]
12. Combining immune checkpoint inhibitor with lenvatinib prolongs survival than lenvatinib alone in sorafenib-experienced hepatocellular carcinoma patients.
Lin PT; Teng W; Jeng WJ; Lin CY; Lin SM; Sheen IS
Eur J Gastroenterol Hepatol; 2022 Feb; 34(2):213-219. PubMed ID: 33177386
[TBL] [Abstract] [Full Text] [Related]
13. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications.
Rhee H; Cho ES; Nahm JH; Jang M; Chung YE; Baek SE; Lee S; Kim MJ; Park MS; Han DH; Choi JY; Park YN
J Hepatol; 2021 Jan; 74(1):109-121. PubMed ID: 32818570
[TBL] [Abstract] [Full Text] [Related]
14. Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis.
He YZ; He K; Huang RQ; Wang ZL; Ye SW; Liu LW; Luo QJ; Hu ZM
Ann Hepatol; 2020; 19(6):654-661. PubMed ID: 32768591
[TBL] [Abstract] [Full Text] [Related]
15. Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma.
Wang L; Jin YX; Ji YZ; Mu Y; Zhang SC; Pan SY
World J Gastroenterol; 2020 Apr; 26(14):1647-1659. PubMed ID: 32327913
[TBL] [Abstract] [Full Text] [Related]
16. Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis.
Sangiovanni A; Alimenti E; Gattai R; Filomia R; Parente E; Valenti L; Marzi L; Pellegatta G; Borgia G; Gambato M; Terreni N; Serio I; Belli L; Oliveri F; Maimone S; Brunacci M; D'Ambrosio R; Forzenigo LV; Russo FP; Rumi M; Barone M; Fracanzani AL; Raimondo G; Giannini EG; Brunetto MR; Villa E; Biganzoli E; Colombo M; Lampertico P
J Hepatol; 2020 Sep; 73(3):593-602. PubMed ID: 32243959
[TBL] [Abstract] [Full Text] [Related]
17. Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma.
Li G; Shen Y; Wang F; Hong S; Cai M
Med Sci Monit; 2020 Feb; 26():e920473. PubMed ID: 32075951
[TBL] [Abstract] [Full Text] [Related]
18. treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv.
Henriksson M; Björnsson B; Sternby Eilard M; Lindell G; Strömberg C; Hemmingsson O; Isaksson B; Rizell M; Sandström P
BJS Open; 2020 Feb; 4(1):109-117. PubMed ID: 32011814
[TBL] [Abstract] [Full Text] [Related]
19. Regression of Fibrosis Stage With treatment Reduces Long-Term Risk of liver cancer in Patients With Hemochromatosis Caused by Mutation in HFE.
Bardou-Jacquet E; Morandeau E; Anderson GJ; Ramm GA; Ramm LE; Morcet J; Bouzille G; Dixon J; Clouston AD; Lainé F; Turlin B; Powell LW; Deugnier YM
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1851-1857. PubMed ID: 31622736
[TBL] [Abstract] [Full Text] [Related]
20. Multicentre study of perioperative
Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K
BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094
[TBL] [Abstract] [Full Text] [Related]
[Next]
